These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1985720)

  • 1. A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; Kvols LK; Rubin J
    Cancer; 1991 Jan; 67(1):33-6. PubMed ID: 1985720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial remission of carcinoid tumor in response to cyproheptadine.
    Leitner SP; Greenberg P; Danieu LA; Michaelson RA
    Ann Intern Med; 1989 Nov; 111(9):760-1. PubMed ID: 2478062
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinoid myopathy and treatment with cyproheptadine (Periactin).
    Berry EM; Maunder C; Wilson M
    Gut; 1974 Jan; 15(1):34-8. PubMed ID: 4274414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
    Kvols LK
    Am J Med; 1986 Dec; 81(6B):49-55. PubMed ID: 2432781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
    Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; Hanley JA
    Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of carcinoid syndrome with recombinant interferon alpha-2a.
    Di Bartolomeo M; Bajetta E; Zilembo N; de Braud F; Di Leo A; Verusio C; D'Aprile M; Scanni A; Barduagni M; Barduagni A [corrected to Barduagni M]
    Acta Oncol; 1993; 32(2):235-8. PubMed ID: 7686766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and prolactin secretion in the carcinoid syndrome.
    Feldman JM; Plonk JW; Bivens CH; Lebovitz HE; Handwerger S
    Am J Med Sci; 1975; 269(3):333-47. PubMed ID: 125543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
    Guadalupe E; Deshpande HA; Stein SM
    Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid syndrome and intravenous cyproheptadine.
    Solares G; Blanco E; Pulgar S; Diago C; Ramos F
    Anaesthesia; 1987 Sep; 42(9):989-92. PubMed ID: 3674361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoid: diagnosis and therapy].
    May B
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2163-5. PubMed ID: 1100341
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenal function in the carcinoid syndrome: effects of the serotonin antagonist cyproheptadine.
    Plank J; Feldman JM
    Metabolism; 1975 Sep; 24(9):1035-46. PubMed ID: 1171350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The control of flushing and diarrhoea in carcinoid syndrome by an antiserotonin agent, BC105.
    Loong SC; Lance JW; Rawle KC
    Med J Aust; 1968 Nov; 2(19):845-8. PubMed ID: 5728213
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of carcinoid tumors.
    Martin RG
    Cancer; 1970 Sep; 26(3):547-51. PubMed ID: 5458261
    [No Abstract]   [Full Text] [Related]  

  • 15. Streptozotocin treatment of metastatic carcinoid tumors.
    Feldman JM; Quickel KE; Marecek RL; Lebovitz HE
    South Med J; 1972 Nov; 65(11):1325-7. PubMed ID: 4263638
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
    Janson ET; Oberg K
    Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
    Kvols LK; Moertel CG; O'Connell MJ; Schutt AJ; Rubin J; Hahn RG
    N Engl J Med; 1986 Sep; 315(11):663-6. PubMed ID: 2427948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid tumors.
    Boushey RP; Dackiw AP
    Curr Treat Options Oncol; 2002 Aug; 3(4):319-26. PubMed ID: 12074768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
    Kvols LK
    Ann N Y Acad Sci; 1994 Sep; 733():464-70. PubMed ID: 7978896
    [No Abstract]   [Full Text] [Related]  

  • 20. Diplopia and diarrhea: ileal carcinoid metastatic to the central nervous system.
    Raymond PL; Balaa MA
    Am J Gastroenterol; 1992 Feb; 87(2):240-3. PubMed ID: 1734706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.